Adrian M. Di Bisceglie
ORCID:0000-0002-6075-9305
发表论文 505 篇 · 总被引 50469 次 · h-index 103
代表论文
- A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes (2021 · Nature Communications · 被引 133)
- Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial (2023 · The American Journal of Gastroenterology · 被引 27)
- A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis (2022 · The American Journal of Gastroenterology · 被引 25)
- Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America (2023 · JAMA Network Open · 被引 23)
- Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B (2022 · The American Journal of Gastroenterology · 被引 19)
- Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy (2024 · Drug Safety · 被引 16)